Geron Corporation

GERN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $16.3M $12.8M $21.2M $42.8M $13.0M $22.1M $16.1M $46.0M
Accounts Receivable — — — — — — — —
Inventory — — — — — — — —
Total Current Assets $96.0M $116.1M $115.9M $153.4M $67.1M $98.4M $125.6M $195.0M
Property, Plant & Equipment $102.0K $183.0K $207.0K $173.0K $92.0K $974.0K $1.2M $3.1M
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $110.3M $130.2M $148.8M $172.5M $67.3M $99.8M $160.0M $233.6M
Liabilities
Accounts Payable $503.0K $225.0K $160.0K $1.0M $1.4M $3.4M $3.0M $3.5M
Total Current Liabilities $6.5M $7.9M $6.6M $41.8M $7.6M $14.1M $13.4M $40.8M
Long-Term Debt — — — — — — — —
Total Liabilities $6.5M $7.9M $6.6M $41.8M $7.6M $14.1M $13.4M $40.8M
Stockholders' Equity
Retained Earnings $-985.8M $-957.9M $-928.4M $-928.4M $-892.8M $-854.4M $-785.5M $-688.7M
Total Stockholders' Equity $103.8M $122.4M $142.1M $130.7M $59.8M $85.7M $146.6M $192.7M
← Newer Page 2 of 2 Older →